ClaimIt 2018 icon

1.0.6.1 by ObvioHealth


Apr 5, 2020

About ClaimIt 2018

ClaimIt is a mobile app to execute clinical trials.

Welcome To ClaimIt:

Obviohealth proprietary platform ClaimIt utilizes a 100% online & mobile app interface to execute clinical trials. ClaimIt removes the costly overhead of physical site visits and brings the trial directly to the mobile device of each subject. The result? Robust data collection, increased compliance, faster time to completion, and average cost savings of ~50% vs. traditional on-site trials.

Subject Journey

A brief introduction into the journey of a subject through the ClaimIt Clinical Trial App:

Subject Recruitment via Targeted Landing Page

• We utilize targeted social media advertising to cost effectively funnel potential subjects to trial specific landing page.

• Each landing page contains details about the parameters of the trial, the benefits of participating, and financial compensation.

Screening Questionnaire

• Subjects that are interested in participating will complete an initial questionnaire designed to automatically screen for subjects that meet defined inclusion criteria.

• Individuals that are not eligible at this time are invited to join the ClaimIt Subject Database and receive invitations to participate in future trials.

Download ClaimIt App

• After passing the initial screening, a study team member may contact each subject to validate responses and ensure that all inclusion criteria are met.

• Subjects that meet all requirements are invited to download the ClaimIt app.

Informed Consent

• Subjects create a ClaimIt account and complete the Informed Consent process. A series of screens explains the parameters of the study, including:

o Privacy Policy

o Data Gathering & Usage

o Study Tasks & Surveys

o Time Commitment

o Option to Withdraw

• Subjects will have the opportunity to connect with a member of the study team to ask questions prior to signing the informed consent form.

Milestone Payments

• Subjects link a PayPal account to the ClaimIt app to receive compensation for participation.

• Milestone payments are structured to incentivize completion of the trial.

Receive Product

• Shortly after enrolling, subjects will receive a package in the mail that contains the products and devices required to complete the trial.

• The subject will submit a picture to confirm the contents of the package arrived safely.

Link Devices

• The ClaimIt app can be linked to a variety of health devices for automatic data collection, including:

o Apple Watch, Fitbit, activity trackers

o Bluetooth scales & blood pressure monitors

o mHealth apps

Intervention Period: Daily Tasks

• Complete Questionnaires/eCRF

o Subjects will contribute data to the study by completeing questionnaires and eCRFs.

• Capture Product compliance

o Subjects can launch the mobile camera within the ClaimIt app to capture images of interactions with the product and document dosage compliance.

• Lab Visit or Online Appointment

o Subjects utilize a study calendar to keep track of their lab visits or virtual appointments with the study team.

• Online video/chat consultation

o Subjects can interact with the study team via face to face video chatting and secure messaging features.

What's New in the Latest Version 1.0.6.1

Last updated on Apr 5, 2020

- A new clinical study integrated
- UI and other enhancements
- Multi-platform support
- Bug fixes

Translation Loading...

Additional APP Information

Latest Version

Request ClaimIt 2018 Update 1.0.6.1

Uploaded by

منيف البنيان

Requires Android

Android 4.4+

Available on

Get ClaimIt 2018 on Google Play

Show More

ClaimIt 2018 Screenshots

Comment Loading...
Languages
Searching...
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Subscribed Successfully!
You're now subscribed to APKPure.
Subscribe to APKPure
Be the first to get access to the early release, news, and guides of the best Android games and apps.
No thanks
Sign Up
Success!
You're now subscribed to our newsletter.